Blessing W.W., Goodchild A.K., Dampney R A L, Chalmers J.P. (1981) Cell groups in the lower brain stem of the rabbit projecting to the spinal cord, with special reference to catecholamine-containing neurons. Brain Res221: 35-55
2.
Charney D.S., Heninger G.R., Sternberg D.E., Roth R.H. (1981) Plasma MHPG in depression: effects of acute and chronic desipramine treatment. Psychiatr Res5: 217-229
3.
Clark D.M. (1991) Proceedings of American Psychiatric Association , New Orleans, 1991
4.
Hsiao J.K., Potter W.Z. (1990) Mechanisms of action of antipanic drugs. In Ballenger J C (ed.), Clinical aspects of panic disorder. Wiley-Liss, New York, pp. 297-317
5.
Linnoila M., Karoum F., Potter W.Z. (1982) Effect of low-dose clorgyline on 24 hour urinary monoamine excretion in patients with rapidly cycling bipolar affective disorder . Arch Gen Psychiatr39: 513-516
6.
Mavissakalian M., Michelson L., Dealy R.S. (1983) Pharmacological treatment of agoraphobia: imipramine vs imipramine with programmed practice. Br J Psychiatr143: 348-355
7.
Mavissakalian M., Michelson L. (1986) Relative and combined effectiveness of therapist-assisted in vivo exposure and imipramine treatment of agoraphobia. Am J Psychiatr143: 1106-1112
8.
Norton G.R., Doward J., Cox B.J. (1986) Factors associated with panic attacks in nonclinical subjects. Behav Ther17: 239-252
9.
Potter W.Z., Sceinin M., Golden R.N., Rudorfer M.V., Cowdry R., Calil H.M., Ross R.J., Linnoila M. (1985) Selective antidepressants and cerebrospinal fluid . Arch Gen Psychiatr42: 1171-1177
10.
Stratton J.R., Halter J.B. (1985) Effect of a benzodiazepine (alprazolam) on plasma epinephrine and norepinephrine levels during exercise stress. Am J Cardiol56:136-139
11.
Telch M.J., Agras W.S., Taylor C.B. (1985) Combined pharmacological and behavioural treatment for agoraphobia. Behav Res Ther23: 325-335
12.
Ziegler G., Ludwig L., Klotz U. (1984) Stress protective effects during steady state conditions of bromazepam. Pharmacopsychiatry17: 194-198
13.
Zitrin C.M., Klein D.F., Woerner M.C. (1980) Treatment of agoraphobia with group exposure in vivo and imipramine. Arch Gen Psychiatr37: 63-72
14.
Zitrin C.M., Klein D.F., Woerner M.G. (1983) Treatment of phobias—1. Comparison of imipramine hydrochloride and placebo. Arch Gen Psychiatr40: 125-138
